Samantha Durland
Obstetrics & Gynecology · Lawrence, KSNPI 1073549622
Payments from drug & device makers
Across 144 payments — averaging $15.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$325
- Currax Pharmaceuticals LLC$223
- Antares Pharma, Inc.$207
- Eisai Inc.$195
- Lilly USA, LLC$154
- Merck$133
- plus $982 from 22 others
What the payments were for
- Food & beverage$2,220100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 25 | $325 |
| Currax Pharmaceuticals LLC | 17 | $223 |
| Antares Pharma, Inc. | 14 | $207 |
| Eisai Inc. | 13 | $195 |
| Lilly USA, LLC | 9 | $154 |
| Merck | 7 | $133 |
| Kvk-tech, Inc. | 1 | $113 |
| AbbVie | 6 | $110 |
| Neurocrine Biosciences, Inc. | 6 | $106 |
| Bausch Health US, LLC | 7 | $93 |
| Supernus Pharmaceuticals, Inc. | 6 | $87 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $55 |
| Therapeuticsmd, Inc. | 4 | $53 |
| Acella Pharmaceuticals, LLC | 3 | $51 |
| Halozyme Inc | 3 | $41 |
| Shield Therapeutics Inc | 2 | $35 |
| Teva Pharmaceuticals USA, Inc. | 2 | $33 |
| Astellas Pharma US Inc | 2 | $31 |
| Arbor Pharmaceuticals, Inc. | 2 | $28 |
| Neos Therapeutics, LP | 2 | $28 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $27 |
| Galderma Laboratories, L.p. | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| Shire North American Group Inc | 1 | $13 |
| Evofem Biosciences, Inc. | 1 | $12 |
| Corium, LLC | 1 | $12 |
| Amgen | 1 | $12 |
| Ascend Therapeutics US, LLC | 1 | $11 |
How this compares
$2,220 in reported general payments places this provider in the 70th percentile of 302 obstetrics & gynecology providers in Kansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 17 | $23,541 |
| Estradiol | 71 | $5,235 |
| ProgesteroneProgesterone, Micronized | 118 | $4,451 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 14 | $2,809 |
| Armour ThyroidThyroid,pork | 11 | $925 |
| Spironolactone | 52 | $732 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 22 | $547 |
| Bupropion XlBupropion Hcl | 20 | $424 |
| Triamcinolone Acetonide | 12 | $353 |
| Oxybutynin Chloride ErOxybutynin Chloride | 12 | $329 |
| Eszopiclone | 18 | $280 |
| Levothyroxine Sodium | 41 | $245 |
| Finasteride | 25 | $225 |
| Minoxidil | 21 | $190 |
| ValacyclovirValacyclovir Hcl | 12 | $165 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $325 | $23,54117 claims |
| AbbVieArmour Thyroid | $110 | $92511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 302 obstetrics & gynecology providers in Kansas.
Other obstetrics & gynecology in Lawrence
- Lynley HolmanLawrence$4K
- Andrea JewellKansas City$3.2M
- Madhuri ReddyKansas City$981K
- Rachel DiteresiKansas City$255K
- Kimberly SwanOverland Park$123K
- Christine SandersHutchinson$82K
- Marci EckHutchinson$73K
- Michael FenechPittsburg$65K
- Anna Stork-FuryWichita$43K
- Michael MageeShawnee Mission$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.